Volitionrx Other Liab from 2010 to 2024

VNRX Stock  USD 0.69  0.01  1.43%   
Volitionrx Other Liabilities yearly trend continues to be fairly stable with very little volatility. Other Liabilities will likely drop to about 281.5 K in 2024. During the period from 2010 to 2024, Volitionrx Other Liabilities regression line of annual values had r-squared of  0.36 and arithmetic mean of  367,014. View All Fundamentals
 
Other Liabilities  
First Reported
2011-12-31
Previous Quarter
420.5 K
Current Value
427.7 K
Quarterly Volatility
225.8 K
 
Yuan Drop
 
Covid
Check Volitionrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Volitionrx's main balance sheet or income statement drivers, such as Interest Expense of 232.7 K, Other Operating Expenses of 38.6 M or Total Operating Expenses of 38.6 M, as well as many indicators such as Price To Sales Ratio of 62.58, Dividend Yield of 0.0 or Days Sales Outstanding of 122. Volitionrx financial statements analysis is a perfect complement when working with Volitionrx Valuation or Volatility modules.
  
Check out the analysis of Volitionrx Correlation against competitors.
For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.

Latest Volitionrx's Other Liab Growth Pattern

Below is the plot of the Other Liab of Volitionrx over the last few years. It is Volitionrx's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Volitionrx's overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Volitionrx Other Liab Regression Statistics

Arithmetic Mean367,014
Geometric Mean340,695
Coefficient Of Variation41.34
Mean Deviation121,174
Median311,042
Standard Deviation151,712
Sample Variance23B
Range446.4K
R-Value(0.60)
Mean Square Error15.8B
R-Squared0.36
Significance0.02
Slope(20,375)
Total Sum of Squares322.2B

Volitionrx Other Liab History

2024281.5 K
2023378.4 K
2022420.5 K
2021253.2 K
2020259.6 K
2019298 K
2018311 K

About Volitionrx Financial Statements

Volitionrx investors use historical fundamental indicators, such as Volitionrx's Other Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Volitionrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Liabilities378.4 K281.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Volitionrx Stock Analysis

When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.